Tag: Terumo

This advertorial is sponsored by Terumo Aortic. On 9 April 2024, a significant milestone was achieved as Terumo Aortic introduced the first implantation of the...

Terumo Medical Corporation has announced late-breaking data showing the safety and efficacy of radial to peripheral (R2P) interventions with the R2P Misago self-expanding peripheral...

Terumo Aortic has announced that the US Food and Drug Administration (FDA) has granted approval of the Thoraflex Hybrid frozen elephant trunk (FET) device...

New data from a head-to-head, randomised trial comparing vascular closure devices, highlights from CX Aortic Vienna 2021 (5–7 October, broadcast) and an interview with past Society...

Terumo Medical Corporation has announced today the introduction of its Azur vascular plug. The addition to Terumo's embolisation portfolio is indicated for use to...

The Roadsaver carotid stent system (Terumo France/Europe and MicroVention Europe) has been reimbursed in France. This follows the positive assessment from the French National...

The US Food and Drug Administration (FDA) has granted premarket approval (PMA) for the Woven EndoBridge (WEB) 17 system from MicroVention, a US-based subsidiary...

  Following approval this year by the US Food and Drug Administration (FDA) of the Treo abdominal aortic stent-graft system for the treatment of patients...

A new post-market study investigating the effectiveness of the Renzan peripheral stent system (Terumo) in patients with peripheral arterial disease (PAD) has been...

The third-generation Anaconda endograft (Terumo Aortic) provides “high technical success” and “satisfactory” five-year aneurysm exclusion and clinical success rates, a French multicentre prospective observational study (EPI-ANA-01) has found. The investigators note that longer-term...

Terumo Corporation today announced that it has decided to acquire Aortica Corporation, a US-based company dedicated to advancing the science of personalised vascular therapy.  Aortica...

Orchestra BioMed, in partnership with Terumo Corporation, today announced that the company has secured breakthrough device designation by the US Food and Drug Administration...

Orchestra BioMed and Terumo have formed a global strategic partnership for the development and commercialisation of Virtue sirolimus-eluting balloon (SEB) in the percutaneous coronary...

Terumo has announced that it acquired CE mark for the Kanshas drug-coated balloon catheter used in the treatment of lower extremity peripheral arterial disease....

Vascutek and Bolton Medical, subsidiaries of Terumo Corporation of Japan, have combined into Terumo Aortic. Combining the aortic companies into a single business, Terumo...

Terumo has entered into a definitive asset purchase agreement with Medeon Biodesign for its XPro large bore vascular closure system. The transaction consists of an...

Tokyo-based Terumo Corporation has announced an investment of £33 million in one of its subsidiary companies, Vascutek Limited, located near Glasgow, UK. According to a...

The first patient has been enrolled in Bolton Medical’s RelayPro US Food and Drug Administration (FDA) Phase II clinical trial. This study will assess the...

Terumo has announced that it has completed its acquisition of certain assets owned by Abbott and St Jude Medical. Terumo has acquired the Angio-Seal and...

Terumo Corporation has announced that it has entered into a definitive agreement under which it has agreed to acquire Bolton Medical from its parent...

Terumo has reached an agreement with Abbott and St Jude Medical to acquire certain products owned by both for a total of US$1.12 billion. Based...

Abbott and St Jude Medical have announced an agreement in principle to sell certain products to Terumo Corporation. The transaction reflects a purchase price of...